LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 106 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q4 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,103 | +350.3% | 1,402,123 | +251.4% | 0.00% | – |
| Q4 2022 | $467 | -99.9% | 399,039 | -21.2% | 0.00% | – |
| Q3 2022 | $572,000 | -64.5% | 506,313 | -50.4% | 0.00% | -100.0% |
| Q2 2022 | $1,612,000 | +486.2% | 1,020,446 | +471.7% | 0.00% | – |
| Q1 2022 | $275,000 | -66.3% | 178,493 | -46.4% | 0.00% | – |
| Q4 2021 | $816,000 | +1565.3% | 333,220 | +1615.4% | 0.00% | – |
| Q3 2021 | $49,000 | -98.5% | 19,425 | -98.6% | 0.00% | -100.0% |
| Q1 2021 | $3,351,000 | +437.0% | 1,425,776 | +301.9% | 0.00% | – |
| Q4 2020 | $624,000 | +86.3% | 354,753 | -0.8% | 0.00% | – |
| Q3 2020 | $335,000 | +2691.7% | 357,528 | +2417.8% | 0.00% | – |
| Q2 2020 | $12,000 | – | 14,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 34,935,485 | $41,223,872 | 3.66% |
| Raffles Associates | 1,587,739 | $1,873,532 | 2.48% |
| Defender Capital, LLC. | 5,184,510 | $6,117,722 | 2.22% |
| Prescott General Partners LLC | 1,851,851 | $2,185,184 | 0.14% |
| DCF Advisers, LLC | 82,751 | $97,646 | 0.05% |
| Beirne Wealth Consulting Services, LLC | 45,000 | $63,450 | 0.05% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 781,766 | $922,484 | 0.02% |
| Fort Sheridan Advisors LLC | 83,931 | $99,039 | 0.02% |
| MAI Capital Management | 954,688 | $1,126,532 | 0.02% |
| Piscataqua Savings Bank | 12,499 | $14,623 | 0.01% |